PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
3.06%
Revenue growth below 50% of VET's 13.22%. Michael Burry would check for competitive disadvantage risks.
-6.05%
Cost reduction while VET shows 16.95% growth. Joel Greenblatt would examine competitive advantage.
8.02%
Gross profit growth 50-75% of VET's 11.68%. Martin Whitman would scrutinize competitive position.
4.82%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.43%
Other expenses growth less than half of VET's 181.91%. David Dodd would verify if advantage is sustainable.
0.86%
Operating expenses growth less than half of VET's 10.78%. David Dodd would verify sustainability.
-3.25%
Total costs reduction while VET shows 13.68% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
0.13%
D&A growth less than half of VET's 25.98%. David Dodd would verify if efficiency is sustainable.
8.16%
EBITDA growth below 50% of VET's 17.77%. Michael Burry would check for structural issues.
-12.23%
EBITDA margin decline while VET shows 4.02% growth. Joel Greenblatt would examine position.
32.10%
Operating income growth exceeding 1.5x VET's 12.47%. David Dodd would verify competitive advantages.
28.17%
Operating margin growth while VET declines. John Neff would investigate advantages.
73.99%
Similar other expenses growth to VET's 77.89%. Walter Schloss would investigate industry patterns.
17.01%
Pre-tax income growth 50-75% of VET's 25.02%. Martin Whitman would scrutinize operations.
13.54%
Pre-tax margin growth 1.25-1.5x VET's 10.42%. Bruce Berkowitz would examine sustainability.
772.34%
Tax expense growth above 1.5x VET's 90.45%. Michael Burry would check for concerning trends.
-37.05%
Net income decline while VET shows 19.13% growth. Joel Greenblatt would examine position.
-38.92%
Net margin decline while VET shows 5.22% growth. Joel Greenblatt would examine position.
-35.36%
EPS decline while VET shows 19.05% growth. Joel Greenblatt would examine position.
-35.27%
Diluted EPS decline while VET shows 18.03% growth. Joel Greenblatt would examine position.
-2.40%
Share count reduction while VET shows 0.40% change. Joel Greenblatt would examine strategy.
-2.46%
Diluted share reduction while VET shows 0.61% change. Joel Greenblatt would examine strategy.